Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Neal Franz

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Pediatric Neurology|May 20, 2025
Long-Term Efficacy and Safety of Mammalian Target of Rapamycin Inhibitor Treatment for Subependymal Giant Cell Astrocytoma in Tuberous SclerosisLena-Luise Becker, Karen Agricola, David M Ritter, et al.
Pediatric Neurology|January 24, 2012
Vigabatrin for childhood partial-onset epilepsiesHansel M Greiner, Elizabeth R Lynch, Steve Fordyce, et al.
Annals of Neurology|February 3, 2006
Rapamycin causes regression of astrocytomas in tuberous sclerosis complexDavid Neal Franz, Jennifer Leonard, Cynthia Tudor, et al.
Cancer Research|August 3, 2007
Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancerLi Ma, Julie Teruya-Feldstein, Pauline Bonner, et al.
Orphanet Journal of Rare Diseases|January 23, 2020
A systematic review on the burden of illness in individuals with tuberous sclerosis complex (TSC)Johann Philipp Zöllner, David Neal Franz, Christoph Hertzberg, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|November 11, 2011
Psychiatric comorbidity and treatment response in patients with tuberous sclerosis complexThomas K Chung, Elizabeth R Lynch, Cheryl J Fiser, et al.
Neurology|November 6, 2016
Long-term treatment of epilepsy with everolimus in tuberous sclerosisDarcy A Krueger, Angus A Wilfong, Maxwell Mays, et al.
The New England Journal of Medicine|November 5, 2010
Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosisDarcy A Krueger, Marguerite M Care, Katherine Holland, et al.
Seizure|June 22, 2018
Calcification in cerebral parenchyma affects pharmacoresistant epilepsy in tuberous sclerosisMeng-Na Zhang, Li-Ping Zou, Yang-Yang Wang, et al.
Annals of Neurology|June 27, 2013
Everolimus treatment of refractory epilepsy in tuberous sclerosis complexDarcy A Krueger, Angus A Wilfong, Katherine Holland-Bouley, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Pediatric Neurology|May 20, 2025
Long-Term Efficacy and Safety of Mammalian Target of Rapamycin Inhibitor Treatment for Subependymal Giant Cell Astrocytoma in Tuberous SclerosisLena-Luise Becker, Karen Agricola, David M Ritter, et al.
Pediatric Neurology|January 24, 2012
Vigabatrin for childhood partial-onset epilepsiesHansel M Greiner, Elizabeth R Lynch, Steve Fordyce, et al.
Annals of Neurology|February 3, 2006
Rapamycin causes regression of astrocytomas in tuberous sclerosis complexDavid Neal Franz, Jennifer Leonard, Cynthia Tudor, et al.
Cancer Research|August 3, 2007
Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancerLi Ma, Julie Teruya-Feldstein, Pauline Bonner, et al.
Orphanet Journal of Rare Diseases|January 23, 2020
A systematic review on the burden of illness in individuals with tuberous sclerosis complex (TSC)Johann Philipp Zöllner, David Neal Franz, Christoph Hertzberg, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|November 11, 2011
Psychiatric comorbidity and treatment response in patients with tuberous sclerosis complexThomas K Chung, Elizabeth R Lynch, Cheryl J Fiser, et al.
Neurology|November 6, 2016
Long-term treatment of epilepsy with everolimus in tuberous sclerosisDarcy A Krueger, Angus A Wilfong, Maxwell Mays, et al.
The New England Journal of Medicine|November 5, 2010
Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosisDarcy A Krueger, Marguerite M Care, Katherine Holland, et al.
Seizure|June 22, 2018
Calcification in cerebral parenchyma affects pharmacoresistant epilepsy in tuberous sclerosisMeng-Na Zhang, Li-Ping Zou, Yang-Yang Wang, et al.
Annals of Neurology|June 27, 2013
Everolimus treatment of refractory epilepsy in tuberous sclerosis complexDarcy A Krueger, Angus A Wilfong, Katherine Holland-Bouley, et al.
Pageof 4